AKT1 and neuroblastoma: This pathway drives the phosphorylation of AKT at threonine 308 (T308) and/or serine 473 (S473), an event that correlates with less overall survival in NB patients with MYCN amplification, 1p36 chromosomal alterations, which drives general decrease in event-free survival [238].